National Comprehensive Cancer Network

New Research in JNCCN Suggests a Simple and Inexpensive Option for Reducing a Major Chemotherapy Side-Effect

PLYMOUTH MEETING, PA — New research in the November 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests that patients who have insufficient levels of vitamin D before starting paclitaxel treatment are more …

New Research in JNCCN Suggests a Simple and Inexpensive Option for Reducing a Major Chemotherapy Side-Effect Read More

National Comprehensive Cancer Network

U.S. Cancer Centers Continue to See Chemotherapy Shortages, According to Update from NCCN

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—a non-profit alliance of leading cancer centers across the United States—has released a follow-up survey on the ongoing chemotherapy shortages: 72% of …

U.S. Cancer Centers Continue to See Chemotherapy Shortages, According to Update from NCCN Read More
National Comprehensive Cancer Network

New Study in JNCCN Highlights Rapid Adoption of Clinical Research Results into Chemotherapy Prescribing Patterns

PLYMOUTH MEETING, PA — New research in the August 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network evaluates how an important analysis on local-regionally advanced colon cancer adjuvant chemotherapy impacted prescribing patterns. The …

New Study in JNCCN Highlights Rapid Adoption of Clinical Research Results into Chemotherapy Prescribing Patterns Read More

National Comprehensive Cancer Network

NCCN Releases Statement Addressing Ongoing Chemotherapy Shortages

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading academic cancer centers—published survey results that shed light on just how widespread the current platinum chemotherapy shortage is, and shared a statement calling …

NCCN Releases Statement Addressing Ongoing Chemotherapy Shortages Read More